| Particulars |
|
|
|
| Company Name
| Concord Biotech Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
10.46 |
B.V. (₹) |
193.10 |
| Sales(₹ Cr.) |
1,055.07 |
NP (₹ Cr.) |
265.72 |
| NP Var (%) |
-25.00 |
Div% |
755.00 |
| CPS(₹) |
32.50 |
EPS (₹) |
25.40 |
| Traded Value(₹ Lakhs) |
848.51 |
52 Week High |
2,150.00 |
| 52 Week Low |
987.00 |
Price BSE |
1,167.00 |
| P/C Ratio |
35.90 |
P/E Ratio |
45.90 |
| Price Vs.BV |
6.04 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
325.89 |
| NP(₹ Cr.) |
90.02 |
NP Var % |
-37.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
1,085.75 |
| OPM |
42.50 |
NP |
328.71 |
| NP Var (%) |
-25.44 |
EPS |
25.40 |
| PE |
45.94 |
|
|